Literature DB >> 32171694

Can frailty screening tools predict completion of chemotherapy and chemotherapy toxicity in patients with thoracic malignancy?

Ann Tivey1, Mohammed Ullah2, Alison Beech2, Cassandra Ng2, Laura Cove-Smith3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32171694     DOI： 10.1016/j.jgo.2020.03.002

Source DB:  PubMed          Journal:  J Geriatr Oncol        ISSN： 1879-4068            Impact factor:   3.599


× No keyword cloud information.
  1 in total

Review 1.  Current challenges of unresectable stage III NSCLC: are we ready to break the glass ceiling of the PACIFIC trial?

Authors:  Jordi Remon; Antonin Levy; Pawan Singh; Lizza E L Hendriks; Mihaela Aldea; Oscar Arrieta
Journal:  Ther Adv Med Oncol       Date:  2022-07-26       Impact factor: 5.485
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.